← Back to headlines
Generic Semaglutide Captures Half of India's Market
Cheaper, generic versions of semaglutide have taken a significant share of the Indian market, impacting the sales of original manufacturer Novo Nordisk. Despite the competition, Novo Nordisk is maintaining its position.
8 May, 08:57 — 8 May, 08:57
Sources
Showing 1 of 1 sources
